Juno Therapeutics Inc. (JUNO) announced after the bell Thursday that the FDA has put its Phase II clinical trial of JCAR015 on a clinical hold after two patients died last week. The deaths followed the recent addition of fludarabine to the pre-conditioning regimen.
from RTT - Before the Bell http://ift.tt/29CzwkO
via IFTTT
No comments:
Post a Comment